Olaptesed pegol: Additional Phase IIa data

Data from 20 evaluable patients with relapsed MM in an open-label, dose-escalation, European Phase IIa trial showed that olaptesed

Read the full 190 word article

How to gain access

Continue reading with a
two-week free trial.